The risk from these specific patents is now eliminated, but the two pending related appeals (2025-1752, 2025-1879) mean the overall patent litigation saga is not fully resolved. Monitor those outcomes for potential further relief or renewed risk.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 8 $174.68entry
- T+1 · 4mo ago +2.00%α +1.15% · $178.17
- T+5 · 4mo ago +3.77%α +2.50% · $181.26
- T+20 · 3mo ago +0.09%α −3.19% · $174.83
- T+60 · 7w ago −16.79%α −19.29% · $145.35
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The Federal Circuit affirmed the district court's summary judgment that two Dental Monitoring SAS patents are invalid under § 101, removing a patent infringement threat against Align Technology's Invisalign Virtual Care AI platform. The nonprecedential ruling is a clear win for Align, but two other related appeals involving the same parties remain pending.
Court Ruling Details
Key Facts
- Federal Circuit affirmed invalidity of claims 1 and 14 of U.S. Patent 11,049,248 and claims 1, 7, and 12 of U.S. Patent 10,755,409 as directed to ineligible subject matter under 35 U.S.C. § 101.
- The ruling is nonprecedential and applies only to the specific patents asserted against Align's Invisalign Virtual Care AI platform.
- Two other appeals (2025-1752 and 2025-1879) involving the same parties and patents are still pending before the Federal Circuit.
Financial Impact
No damages were awarded or quantified in the opinion; the ruling eliminates a potential liability for Align but the financial exposure was never stated in the document.
Risk Factors
- Two other related appeals are still pending, which could revive patent infringement risk if the Federal Circuit rules differently on the remaining patents.
- The nonprecedential nature of this ruling limits its value as a defense against other patent assertions by Dental Monitoring or other parties.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-b60e07b593-ALGN |
Track record
19 reports on ALGN
3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +12.30% at T+60 after the Aug 3, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $168.32 Now $165.98 −1.39% settles Dec 14
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $172.08 Now $165.98 −3.54% settles Dec 10
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $166.00 Now $165.98 −0.01% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $159.37 Now $165.98 +4.15% settles Dec 4
- Nov 2, 202614d ago 3 Neutral 1/10 Entry $151.58 Now $165.98 +9.50% settles Dec 2
- Oct 28, 202619d ago 8-K Neutral 3/10 Entry $153.71 Now $165.98 +7.98% settles Nov 27
- Oct 28, 202619d ago 8-K Neutral 5/10 Entry $153.71 Now $165.98 +7.98% settles Nov 27
- Oct 21, 202627d ago PTAB Trial Mixed 6/10 Entry $155.51 Now $165.98 +6.73% settles Nov 19
- Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $148.90 to $165.98 Now $165.98 −11.47% ▼ −11.47% −14.93% vs SPY
- Aug 31, 202611w ago 8-K Neutral 2/10 Entry $154.96 to $145.35 Now $165.98 +7.11% ▼ −6.20% −6.52% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers